Post by
Marcel7 on Jun 04, 2016 5:24pm
What action could UK government take?
This from the daily mail article: A Department of Health spokesman said: 'No pharmaceutical company should be exploiting the NHS. The Competition and Markets Authority is already investigating a potential abuse of generics pricing, and as part of a public consultation we have asked for views on government powers to limit the prices of generic medicines where there is no competitive market.' Read two things here. One: they are investigating "A" potential abuse of generics pricing. My understanding is "a" typically means one. Two : "WHERE THERE IS NO COMPETITIVE MARKET." I believe that most AMCO drugs do have a competitor. Furthermore, at what price are these drugs profitable? What if usage has dropped off and it has become somewhat of a niche product? You cannot force a company to produce these products at a loss. If they change the pricing environment it has consequences on availability of these niche medicines or dosages. My understanding os that the UK already have pretty strict regulations regarding pricing, this was a loophole, not the norm, do given a large portfolio of drugs it is unlikely that many are likely to be impacted. Does anyone have access to The Times article? Does it have a more detailed list of the alleged off encoding drugs? We can then cross reference these against CXR/AMCO portfolio to see if there is any relevance at all. Marcel
Comment by
Marcel7 on Jun 04, 2016 5:38pm
Damn autocorrect. Offending not "off encoding"...corrected in quotes.
Comment by
Marcel7 on Jun 04, 2016 6:57pm
Yeah. I was asking if anyone had read or has access to The Times article. It is behind a pay wall and appears to be the source of this article. I guess I will pony up a few pounds for a subscription. Marcel
Comment by
PirateEquity on Jun 04, 2016 6:11pm
Laugh then check with their US Government counterparts on what wisdom they have read in The National Enquire. ... Very intelligent discussions here chaps! Keep going.